Ranibizumab Modifies the Expression of Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Mononuclear Cells in Patients with Exudative Age-Related Macular Degeneration.

Published in: Journal of clinical medicine (2024)

, in particular, may play a role in the treatment response, but further research is necessary.

Keyphrases